Tops & Flops Stocks
| Security | Change (%) ▼ | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Teligent Inc. | 725.000% | - | - | - | - | - | - |
| ImmunityBio Inc. | 42.890% | 3.053% | -5.762% | 122.383% | 0.826% | -69.289% | - |
| Avenue Therapeutics Inc. | 22.820% | -12.419% | -21.076% | -88.354% | -27.016% | - | - |
| F-Star Therapeutics Inc. | 18.750% | - | - | - | - | - | - |
| Acelrx Pharmaceuticals Inc. | 15.320% | -7.210% | -13.112% | 41.853% | 25.424% | -95.511% | -98.676% |
| Seres Therapeutics Inc | 14.410% | 15.326% | -4.959% | -87.720% | -47.038% | -95.891% | - |
| Ziopharm Oncology | 11.930% | - | - | - | - | - | - |
| Natural Alternat. | 10.530% | -5.000% | 5.556% | -28.750% | -0.870% | -55.469% | -50.279% |
| Alimera Sciences | 9.190% | - | - | - | - | - | - |
| AC Immune Ltd | 8.880% | -4.889% | -21.033% | 20.631% | -51.142% | -61.888% | - |
| Geron Corp. | 7.910% | -5.057% | 10.619% | 51.459% | 68.852% | 170.603% | 101.150% |
| Infinity Pharmaceuticals Inc. | 7.360% | - | - | - | - | - | - |
| Viking Therapeutics Inc | 7.230% | 5.592% | -0.156% | 254.305% | 267.172% | 1189.416% | - |
| Canopy Growth Corp | 7.100% | - | - | - | - | - | - |
| Athersys Inc. | 6.990% | - | - | - | - | - | - |
| AquaBounty Technologies Inc | 6.640% | - | - | - | - | - | - |
| Capricor Therapeutics Inc | 6.580% | 0.737% | -22.195% | 32.917% | 6.927% | 47.685% | - |
| Mediwound Ltd. | 6.580% | -5.590% | 4.828% | 47.573% | 68.889% | 306.417% | 236.134% |
| Abeona Therapeutics Inc. | 6.080% | -58.310% | -57.955% | 5.488% | -37.155% | -91.131% | - |
| BeiGene Ltd ADR | 5.690% | 4.839% | -8.451% | -44.444% | -21.212% | -50.758% | - |
| Adocia | 5.570% | -3.580% | -8.286% | 189.088% | -31.293% | -16.872% | -48.666% |
| BioLine RX Ltd ADR | 5.560% | -10.744% | -55.372% | -48.077% | -61.972% | -76.724% | -99.245% |
| Nymox Pharmaceutical Corp. | 5.410% | - | - | - | - | - | - |
| Rocket Pharmaceuticals Inc | 5.090% | -0.523% | 0.113% | 35.591% | -4.654% | -41.601% | 76.124% |
| Eidos Therapeutics | 5.050% | - | - | - | - | - | - |